Health
Putting the ‘STING’ on CAR-T cells to turn them against breast cancer and other solid tumors – FierceBiotech
Activating the immune pathway STING creates an inflammatory environment that should improve immuno-oncology treatments, but clinical trials have been disappointing…
The immune pathway known as stimulator of interferon genes (STING) has long been of interest in the oncology community because activating it creates an inflammatory environment that should improve the ability of immune cells to attack cancer. But experimental STING-activating treatments have produced mixed results in clinical trials.
Researchers at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center have promising evidence that adding STING activators to CAR-T cell therapies…
-
General20 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
Noosa News19 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General12 hours agoAlgal bloom fears grow as video shows dead fish in ‘neon green’ waters near Ardrossan
-
Business18 hours agoAdd these 2 satellite ETFs to your core ASX stock portfolio